Curcumin nanoformulations: Beneficial nanomedicine against cancer
Citations Over TimeTop 10% of 2022 papers
Abstract
Curcumin is a phytochemical achieved from the plant turmeric. It is extensively utilized for the treatment of several types of diseases such as cancers. Nevertheless, its efficiency has been limited because of rapid metabolism, low bioavailability, poor water solubility, and systemic elimination. Scientists have tried to solve these problems by exploring novel drug delivery systems such as lipid-based nanoparticles (NPs) (e.g., solid lipid NPs, nanostructured lipid carriers, and liposomes), polymeric NPs, micelles, nanogels, cyclodextrin, gold, and mesoporous silica NPs. Among these, liposomes have been the most expansively studied. This review mainly focuses on the different curcumin nanoformulations and their use in cancer therapy in vitro, in vivo, and clinical studies. Despite the development of curcumin-containing NPs for the treatment of cancer, potentially serious side effects, including interactions with other drugs, some toxicity aspects of NPs may occur that require more high-quality investigations to firmly establish the clinical efficacy.
Related Papers
- → Curcumin‐free turmeric exhibits anti‐inflammatory and anticancer activities: Identification of novel components of turmeric(2013)311 cited
- → The antitoxic and protective effects of Curcuma longa and it`s active agent, Curcumin: оverview(2020)3 cited
- IN-VITRO STUDIES ON TURMERIC (CURCUMA)(2015)
- CURCUMIN - HEALTH PROMISE FOR THE FUTURE(2015)
- → STABILITY OF ‘SUBMICRON CURCUMIN’ FROM CURCUMA LONGA L. IN AQUEOUS MEDIA(2011)